Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
If Democrats weren't miffed enough at Big Pharma after news reports suggested the industry hiked prices to offset the impact of the overhaul, the flames could be fanned by a new study that finds companies may also have passed advertising costs on to... Full Article at NPR
Today Asher Mullard Please Login to read the full article. Full Article at Scrip News
This undated handout photo provided by Bristol-Myers Squibb Co. shows CEO James M. Cornelius. Bristol-Myers Squibb Co. View Photo »
These recommendations are based upon recently submitted studies by the manufacturer of clopidogrel [Sanofi-Aventis and Bristol-Myers Squibb]
Does pharma's consumer advertising increase sales--or just prices? Full Article at FiercePharma
Research partnership between Asterand and Bristol-Myers will be extended for 3 more years. Asterand, will continue to provide drug discovery services and human tissue and clinical samples to Bristol-Myers Squibb. Full Article at TransWorldNews
Over the last decade, the treatment of chronic myelogenous leukemia has been revolutionized - first by Gleevec (Novartis) , and then by Tasigna (Novartis) and Sprycel (Bristol-Myers Squibb) - the tyrosine kinase inhibitor (TKI) class. Full Article at Gerson Lehrman Group
In this photo provided by Bristol-Myers Squibb, David Martin whose reflection appears at left, studies a photo at an exhibit that was submitted to the national "Fight HIV Your Way" photo contest sponsored by Bristol-Myers Squibb in San Francisco, Wednes... View Photo »
* Approved to treat aggression, self injury, tantrums * Drug indicated as part of treatment program LOS ANGELES (Reuters) - The U.S. Food and Drug Administration has approved Bristol-Myers Squibb Co's and Otsuka Pharmaceutical Co's anti-psychotic drug... Full Article at Reuters Health: eLine
The price of Plavix for the Medicaid insurance plan for the poor rose 12 percent “immediately” after consumer ads began in 2001, according to a study released today in the Archives of Internal Medicine. Full Article at Bloomberg.com
There are no results for this module. Edit this module to change the search term used to query Wikipedia
This undated handout photo provided by Bristol-Myers Squibb Co. shows CEO James M. Cornelius. Bristol-Myers Squibb Co.
View Photo »In this photo provided by Bristol-Myers Squibb, David Martin whose reflection appears at left, studies a photo at an exhibit that was submitted to the national "Fight HIV Your Way" photo contest sponsored by Bristol-Myers Squibb in San Francisco, Wednesday, Oct. 28, 2009.
View Photo »FILE - In this July 28, 2006 file photo, blood thinner medication Plavix is shown July in New York.
View Photo »FILE- In this Sept. 23, 2009 file photo, a technician works at the Medarex Inc. production facility in Bloomsbury, N.J. New York based drug maker Bristol-Myers Squibb Co. announced on Wednesday, July 22, 2009 that it is buying the Princeton, N.J. based company for about $2.1 billion in...
View Photo »FILE- In this Sept. 23, 2009 file photo, a technician works at the Medarex Inc. production facility in Bloomsbury, N.J. New York based drug maker Bristol-Myers Squibb Co. announced on Wednesday, July 22, 2009 that it is buying the Princeton, N.J. based company for about $2.1 billion in...
View Photo »FILE - In this July 28, 2006 file photo, blood thinner medication Plavix is shown in a New York. Strong sales of two blockbuster drugs helped boost revenue for Bristol-Myers Squibb Co. , but higher taxes and a litigation charge pulled down its first-quarter profit a bit.
View Photo »FILE - In this June 15 2005 file photo, a sign stands in front of the Bristol-Myers Squibb Company's headquarters in Lawrence Township, N.J. Strong sales of two blockbuster drugs helped boost revenue for Bristol-Myers Squibb Co.
View Photo »In this photo provided by Bristol-Myers Squibb, David Martin whose reflection appears at left, studies a photo at an exhibit that was submitted to the national "Fight HIV Your Way" photo contest sponsored by Bristol-Myers Squibb in San Francisco, Wednesday, Oct. 28, 2009.
View Photo »These recommendations are based upon recently submitted studies by the manufacturer of clopidogrel [Sanofi-Aventis and Bristol-Myers Squibb]
Bristol-Myers Squibb and Alder share the vision that ALD518 could become an important part of treating patients with rheumatoid arthritis
Like Bristol-Myers Squibb, The Pennington School is committed to research and scientific investigation
Our lasting relationship with Bristol-Myers Squibb is representative of the reliability of our solutions, services and support teams, which we will continue to make every effort to deliver throughout our collaboration with the Bristol-Myers Squibb clinical team
The European Commission decision marks an important milestone in the alliance between Bristol-Myers Squibb and AstraZeneca. Our legacy in treating type 2 diabetes and cardiovascular disease, together with our knowledge and expertise, enables us to deliver to patients a medicine that will offer further c...
Diabetes is a growing epidemic currently affecting some 53 million people in Europe with the number of cases expected to increase. Today’s announcement is good news for those affected by type 2 diabetes and further demonstrates the commitment of AstraZeneca and Bristol-Myers Squibb to bring much needed ...
The data on Bristol-Myers Squibb compounds that will be presented at AASLD demonstrate the breadth of our research and development portfolio and support the company’s goal of developing innovative medicines for patients with various diseases of the liver
Our relationship with Bristol-Myers Squibb has extended over ten years
This award recognizes Prescient's efforts to reduce heart attack deaths using our Shield, the first product specifically designed to treat soft, vulnerable plaques ... We believe the Shield will change the treatment paradigm from repairing damage after a patient has had a heart attack to preventing plaq...
This planned divestiture is a part of Bristol-Myers Squibb's strategic transformation into a more focused next-generation BioPharma company that develops and commercializes products that address serious unmet medical needs
We are proud to partner with the P.A.D. Coalition and their membership of committed partners on this very important initiative. Special thanks to the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership for their visionary leadership, their commitment to ending health disparities among the underserve...
Our relationship with Bristol-Myers Squibb has extended over ten years ... Over that time we have seen the regulatory requirements of the industry evolve the services we deliver from a meeting planning operation to a cross functional discipline. We look forward to continuing our collaboration with Brist...
Bristol-Myers Squibb 8941 http://sailingscoop.com/index.php?search=Bristol-Myers+Squibb
- gamingscoop 8 hours ago
- CherylAnnBorne
20 hours ago
- ahomefas
20 hours ago
- pharma_marketer
1 day ago
- cafepharma
1 day ago
